Summary
In the IBREST trial, when compared with placebo, a novel targeted delivery system of peppermint oil is more effective in treating symptoms of nonconstipated irritable bowel syndrome at 4 weeks. The trial shows significant improvement in the Total IBS Symptoms Score and 4 of 8 symptom domains. Furthermore, the treatment appears safe and well tolerated.
- irritable bowel syndrome
- IBS
- peppermint oil
- targeted release
- IBREST
- gastroenterology clinical trials
- © 2015 SAGE Publications
Tools
Table of contents
Cited By...
- No citing articles found.